Severe Varicella in Children Under Five Years of Age in the Context of Herd Immunity, Vaccine Hesitancy, and the COVID-19 Pandemic in Brazil, 2008-2023
Abstract
Objective: Varicella (chickenpox) is a highly contagious disease, and its vaccine was incorporated into the Brazilian National Immunization Program in 2013. Objectives: (i) To analyze trends in hospitalization rates for severe chickenpox by age; (ii) To assess the impact of the interventions “anti-vaccine movement/vaccine hesitancy” and “COVID-19 pandemic” on hospitalization rates.
Materials and methods: Classical Time Series (CTS) and Interrupted Time Series (ITS) methods were applied to estimate the impact of the anti-vaccine movement/vaccine hesitancy (intervention-1) that occurred in 2016 and the COVID-19 pandemic (intervention-2) that began in 2020 on hospitalization rates among children under 5 years old, stratified by groups based on vaccine-ineligible (< 1 year old) and vaccine-eligible (1-4 years old) children.
Results: CTS results supported the potential for herd immunity effects, showing an annual decline of
-17% and -14% in hospitalization rates for vaccine-eligible (1-4 years) and vaccine-ineligible (< 1 year) groups, respectively. The ITS model for vaccine-ineligible children showed an upward trend (coefficient 0.35) after intervention-1(isolate) (p=0.001), as well as after intervention-1 (coefficient 0.42; p 0.011) adjusting for intervention-2 (p=0.135). For vaccine-eligible children, the ITS model revealed an upward trend (coefficient 0.14) only after intervention-1 (isolate) (p=0.006).
Conclusion: The decline in varicella hospitalizations indicates a herd immunity effect among vaccine-ineligible children. ITS analysis reveals that the anti-vaccine movement/vaccine hesitancy contributed to increased hospitalizations in both vaccine-eligible (1-4 years) and vaccine-ineligible (<1 year) groups, while the COVID-19 pandemic had no discernible impact.
2. Gershon AA, Gershon MD, Shapiro ED. Live attenuated varicella vaccine: prevention of varicella and of zoster. J Infect Dis. 2021;224(Suppl 2):S387–S397.
3. Domingues CMAS, Maranhão AGK, Teixeira AM, Fantinato FFS, Domingues RAS. The Brazilian National Immunization Program: 46 years of achievements and challenges. Cad Saude Publica. 2020;36(Suppl 2):e00222919.
4. European Centre for Disease Prevention and Control. Varicella vaccination in the European Union. Stockholm: ECDC; 2015. Available from: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/Varicella-Guidance-2015.pdf. Accessed 2015 Jul 23.
5. Brazil. Ministry of Health. Health Surveillance Department. Health Surveillance Guide. 1st ed. Brasília: Ministry of Health; 2017.
6. Egeskov Cavling AM, Johannesen CK, Folke F, Fischer TK. Evaluating the impact of moderate and severe varicella infections on Danish children under 18 years old: a comprehensive analysis from 2015 to 2023. Pediatr Infect Dis J. 2025;44(3):270–276.
7. Ramos ACLC, Pacheco BAB, Sousa JEA, Petrilli JD, Costa GNO. Vaccination coverage and anti vaccine movement: the impact on public health in Brazil. Rev Baiana Saude Publica. 2023;47(1):210–226.
8. Gowda C, Dempsey AF. The rise (and fall?) of parental vaccine hesitancy. Hum Vaccin Immunother. 2013;9(8):1755–1762.
9. Antunes JLF, Cardoso MRA. Using time series analysis in epidemiological studies. Epidemiol Serv Saude. 2015;24(3):565–576.
10. Brazil. Ministry of Health. Department of Informatics of the Unified Health System (DATASUS) [Internet]. Available from: https://datasus.saude.gov.br/. Accessed 2026 Feb 11.
11. Brazil. Brazilian Institute of Geography and Statistics (IBGE). Population projections [Internet]. Available from: https://www.ibge.gov.br/estatisticas/sociais/populacao/9109-projecao-da-populacao.html. Accessed 2026 Feb 11.
12. Prais SJ, Winsten CB. Trend estimators and serial correlation. Chicago: Cowles Commission; 1954. (CCDP Stat; no. 383).
13. Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–355.
14. Sato APS. What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil? Rev
Saude Publica. 2018;52:96.
15. Melo CML, Silva GAS, Melo ARS, Freitas AC. COVID 19 pandemic outbreak: the Brazilian reality from the first case to the collapse of health services. An Acad Bras Cienc. 2020;92(4):e20200709.
16. Durbin J, Watson GS. Testing for serial correlation
in least squares regression. Biometrika. 1951;
38(1-2):159–178.
17. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2023. Available from: https://www.r-project.org/.
18. Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella related hospitalization rates. Vaccine. 2013;31(42):4744–4748.
19. Lee T, Suh J, Choi JK, Lee J, Park SH. Estimating the basic reproductive number of varicella in South Korea incorporating social contact patterns and seroprevalence. Hum Vaccin Immunother. 2021;17(8):2488–2493.
20. Ribeiro MZ, Kupek E, Ribeiro PVZ, Pinheiro CEA. Impact of the tetra viral vaccine introduction on varicella morbidity and mortality in the Brazilian macro regions. J Pediatr (Rio J). 2020;96(6):702–709.
21. Nuwarda RF, Ramzan I, Weekes L, Kayser V. Vaccine hesitancy: contemporary issues and historical background. Vaccines (Basel). 2022 Sep 22;10(10):1595.
22. Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312–315.
23. Ashby B, Best A. Herd immunity. Curr Biol. 2021;31(4):R174–R177.
| Files | ||
| Issue | Vol 20, No 2 (June 2026) | |
| Section | Original Articles | |
| Keywords | ||
| Varicella Vaccination Notification Hospitalization COVID-19 Vaccination Hesitancy Interrupted Time Series Analysis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |

